Education
About Us
Working with TipRanks
Follow Us
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
RESEARCH TOOLSreports
Technical Sentiment
Overall Consensus
Strong Sell
2Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
2Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
TransCode Therapeutics’s (RNAZ) Moving Averages Convergence Divergence (MACD) indicator is -1.47, suggesting TransCode Therapeutics is a Sell.
TransCode Therapeutics’s (RNAZ) 20-Day exponential moving average is 7.82, while TransCode Therapeutics’s (RNAZ) share price is $6.97, making it a Sell.
TransCode Therapeutics’s (RNAZ) 50-Day exponential moving average is 20.65, while TransCode Therapeutics’s (RNAZ) share price is $6.97, making it a Sell.
TransCode Therapeutics (RNAZ) Pivot Points
Classic
6.21
6.69
6.95
7.43
7.68
8.16
8.42
Fibonacci
6.69
6.97
7.15
7.43
7.71
7.88
8.16
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
TransCode Therapeutics (RNAZ) Moving Averages
MA5
7.32Sell
7.21Sell
MA10
7.25Sell
7.27Sell
MA20
7.22Sell
7.82Sell
MA50
9.37Sell
20.65Sell
MA100
70.40Sell
70.40Sell
MA200
197.21Sell
205.09Sell
TransCode Therapeutics’s (RNAZ) 10-Day exponential moving average is 7.27, while TransCode Therapeutics’s (RNAZ) share price is $6.97, making it a Sell.
TransCode Therapeutics’s (RNAZ) 100-Day exponential moving average is 70.40, while TransCode Therapeutics’s (RNAZ) share price is $6.97, making it a Sell.
TransCode Therapeutics’s (RNAZ) stock price is $6.97 and TransCode Therapeutics’s (RNAZ) 50-day simple moving average is 9.37, creating a Sell signal.
TransCode Therapeutics’s (RNAZ) stock price is $6.97 and TransCode Therapeutics’s (RNAZ) 100-day simple moving average is 70.40, creating a Sell signal.
TransCode Therapeutics’s (RNAZ) stock price is $6.97 and TransCode Therapeutics’s (RNAZ) 200-day simple moving average is 197.21, creating a Sell signal.
TransCode Therapeutics (RNAZ) Technical Indicators
RSI (14)
36.54
Neutral
STOCH (9,6)
34.50
Neutral
STOCHRSI (14)
42.89
Neutral
MACD (12,26)
-1.47
Sell
ADX (14)
5.20
Buy
Williams %R
-73.78
Buy
CCI (14)
-37.67
Neutral
ATR (14)
1.27
-
Ultimate Oscillator
30.40
Neutral
ROC
0.00
Sell
TransCode Therapeutics’s (RNAZ) Relative Strength Index (RSI) is 36.54, creating a Neutral signal.
TransCode Therapeutics’s (RNAZ) Trend Strength Indicator (ADX) is 5.20, creating a Buy signal.
TransCode Therapeutics’s (RNAZ) Commodity Channel Index (CCI) is -37.67, creating a Neutral signal.
FAQ
Is RNAZ a Buy, Hold, or Sell?
Based on RNAZ’s technical indicators, RNAZ is a Strong Sell.
What is RNAZ’s RSI (14)?
RNAZ’s RSI (14) is 36.54, which suggests RNAZ is a Neutral.
What is RNAZ’s MACD?
RNAZ’s MACD is -1.47, which suggests RNAZ is a Sell.
What is RNAZ’s 5-day moving average?
RNAZ’s 5-day moving average is 7.32, which suggests RNAZ is a Sell.
What is RNAZ’s 20-day moving average?
RNAZ 20-day moving average is 7.22, which suggests RNAZ is a Sell.
What is RNAZ’s 50-day moving average?
RNAZ’s 50-day moving average is 9.37, which suggests RNAZ is a Sell.
What is RNAZ’s 200-day moving average?
RNAZ’s 200-day moving average is 197.21, which suggests RNAZ is a Sell.
What is RNAZ’s Williams % R (14)?
RNAZ’s Williams % R (14) is -73.78, which suggests RNAZ is a Buy.
What is RNAZ’s CCI (14)?
RNAZ’s CCI (14) is -37.67, which suggests RNAZ is a Neutral.